Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.43 - $5.9 $1.01 Million - $13.8 Million
-2,340,990 Reduced 52.94%
2,080,656 $1.2 Million
Q2 2022

Aug 15, 2022

BUY
$0.38 - $0.64 $1.6 Million - $2.7 Million
4,213,348 Added 2022.75%
4,421,646 $2.11 Million
Q1 2022

May 16, 2022

SELL
$0.55 - $0.98 $338,489 - $603,127
-615,436 Reduced 74.71%
208,298 $140,000
Q4 2021

Feb 14, 2022

BUY
$0.9 - $1.31 $621,991 - $905,343
691,102 Added 521.07%
823,734 $812,000
Q3 2021

Nov 15, 2021

SELL
$1.21 - $1.61 $423,491 - $563,488
-349,993 Reduced 72.52%
132,632 $170,000
Q2 2021

Aug 16, 2021

SELL
$1.6 - $2.02 $1.26 Million - $1.59 Million
-788,927 Reduced 62.04%
482,625 $787,000
Q1 2021

May 17, 2021

BUY
$1.86 - $2.87 $2.34 Million - $3.62 Million
1,260,404 Added 11306.1%
1,271,552 $2.52 Million
Q4 2020

Feb 16, 2021

BUY
$1.65 - $2.43 $18,394 - $27,089
11,148 New
11,148 $23,000
Q2 2020

Aug 14, 2020

SELL
$1.33 - $2.76 $6.06 Million - $12.6 Million
-4,554,026 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$0.97 - $2.85 $1.18 Million - $3.48 Million
1,220,465 Added 36.61%
4,554,026 $7.06 Million
Q4 2019

Feb 14, 2020

BUY
$1.69 - $3.8 $4.76 Million - $10.7 Million
2,816,376 Added 544.56%
3,333,561 $12.7 Million
Q3 2019

Nov 14, 2019

SELL
$0.61 - $2.21 $697,552 - $2.53 Million
-1,143,529 Reduced 68.86%
517,185 $951,000
Q2 2019

Aug 15, 2019

BUY
$0.51 - $0.86 $750,655 - $1.27 Million
1,471,874 Added 779.43%
1,660,714 $1.08 Million
Q2 2019

Aug 14, 2019

BUY
$0.51 - $0.86 $96,308 - $162,402
188,840 New
188,840 $13.9 Million
Q3 2018

Nov 14, 2018

SELL
$1.06 - $1.69 $31,873 - $50,816
-30,069 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$1.56 - $2.51 $1.02 Million - $1.65 Million
-656,616 Reduced 95.62%
30,069 $47,000
Q1 2018

May 15, 2018

BUY
$0.91 - $2.24 $378,491 - $931,672
415,925 Added 153.61%
686,685 $1.47 Million
Q4 2017

Feb 14, 2018

SELL
$0.78 - $2.1 $991,276 - $2.67 Million
-1,270,867 Reduced 82.44%
270,760 $250,000
Q3 2017

Nov 14, 2017

BUY
$1.55 - $1.82 $2.39 Million - $2.81 Million
1,541,627
1,541,627 $2.73 Million

Others Institutions Holding DRRX

About DURECT CORP


  • Ticker DRRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 227,794,000
  • Market Cap $230M
  • Description
  • DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...
More about DRRX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.